Even moderate daily walking, specifically around 3,000 steps, may offer a way for older individuals at higher risk of Alzheimer’s disease to mitigate cognitive decline.
The precise mechanism behind this potential benefit remains a subject of investigation. Researchers suggest it could be linked to exercise’s positive effects on reducing inflammation within the body or enhancing blood circulation to the brain. Previous studies examining the connection between physical activity and reduced cognitive deterioration have largely relied on self-reported activity levels. These studies have also commonly failed to thoroughly explore the underlying reasons for this association.
To overcome these limitations, a research team led by Wai-Ying Wendy Yau at Harvard University undertook an objective assessment of physical activity. They equipped 296 cognitively healthy participants, aged between 50 and 90, with step-tracking devices for a single week. This allowed for the precise measurement of their individual activity levels.
Investigating Brain Health and Activity Levels
A significant portion of the participants underwent brain imaging. This imaging was conducted to establish baseline levels of misfolded proteins, specifically tau and beta-amyloid. These protein clumps are widely believed to be a significant contributor to Alzheimer’s disease. These protein levels were subsequently monitored at intervals of two to three years over a follow-up period that spanned 3 to 14 years. Concurrently, participants completed annual cognitive assessments designed to evaluate aspects such as memory function and information processing speed.
By integrating data from step counts, brain imaging results, and cognitive test outcomes into a sophisticated statistical model, the researchers were able to estimate the influence of exercise on the rate of cognitive decline. Their findings indicated that participants who exhibited higher-than-average levels of misfolded beta-amyloid protein in their brains at the study’s outset experienced a substantial deceleration in the accumulation of misfolded tau protein when they took between 3,000 and 5,000 steps daily. This effect, however, did not appear to impact beta-amyloid levels.
Tau Protein and Cognitive Decline Rates
Charles Marshall of Queen Mary University of London commented that “Exercise is somehow slowing the spread of this tau protein, which is more strongly associated with people developing symptoms [of Alzheimer’s disease] than amyloid-beta.”
This observed reduction in tau protein accumulation also correlated with a slower rate of cognitive decline. Over an average follow-up period of nine years, participants who walked between 3,000 and 5,000 steps per day showed approximately a 40 percent decrease in their cognitive decline rate compared to those who were less active, defined as taking fewer than 3,000 steps daily. The study did not have sufficient data to determine if any participants were formally diagnosed with Alzheimer’s disease during the observation period.
Further increasing daily steps to between 5,000 and 7,500 appeared to further inhibit tau accumulation. This led to a 54 percent slower cognitive decline rate relative to the inactive group. However, the benefits seemed to plateau beyond 7,500 steps per day. “Those tau and cognitive benefits eventually plateau,” Yau stated.
Potential Mechanisms and Study Limitations
The researchers did not pinpoint the exact biological pathways through which regular exercise might exert these effects. One possibility is that physical activity reduces inflammation, a process thought to be triggered by the misfolded beta-amyloid and tau proteins, which can subsequently damage neural connections and lead to cell death. Exercise might also enhance blood flow to the brain or increase levels of a neuroprotective hormone.
Despite these promising findings, this study does not definitively establish a cause-and-effect relationship between walking 5,000 steps daily and slowed or delayed cognitive decline. Marshall pointed out that pre-existing cognitive impairments, which might not yet be diagnosed or even noticeable to individuals, could influence their capacity or inclination to exercise. He also suggested that other lifestyle factors or socioeconomic influences, some of which the research team attempted to account for, could similarly impact both physical activity levels and tau protein concentrations.
Nevertheless, the established numerous health advantages of consistent physical activity, coupled with its accessibility and minimal side effects, might encourage individuals to aim for at least 3,000 steps per day, even if the precise impact on cognitive function remains under investigation. Marshall advises individuals not to become overly focused on a specific “magic number” for their step goal. He emphasizes that consistency in physical activity, even at modest levels or lower intensity, is more critical than reaching a particular quantitative target.
Prior research has indicated that sustained lifestyle changes, including incorporating regular exercise, can lead to improvements in cognitive function. However, Yau stressed the need for further studies involving randomized assignments of participants to different daily step counts. Such studies would be crucial to disentangle the specific effects of exercise from other lifestyle modifications and to firmly establish whether it genuinely slows tau accumulation.